QNRX
Quoin Pharmaceuticals Ltd ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.06
-0.03 ▼ -0.37%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$8.29
+0.22 ▲ +2.79%
| Index | - | P/E | - | EPS (ttm) | -470.08 | Insider Own | - | Shs Outstand | 0.00B | Perf Week | -7.04% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 78.27% | Insider Trans | - | Shs Float | - | Perf Month | 0.5% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -4.02 | Inst Own | 145.89% | Short Float | - | Perf Quarter | -32.38% |
| Income | -0.01B | P/S | - | EPS this Y | 69.85% | Inst Trans | 15.54% | Short Ratio | 0.43 | Perf Half Y | 6.75% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 83.69% | ROA | -155.66% | Short Interest | 0.01M | Perf YTD | -44.14% |
| Book/sh | -2.07 | P/C | 0.88 | EPS past 3/5Y | -421.41% -144.05% | ROE | -655.97% | 52W High | -80.72% ($41.80) | Perf Year | -21.94% |
| Cash/sh | 9.17 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 60.88% ($5.01) | Perf 3Y | -96.29% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -228.89% | Gross Margin | - | Volatility(W/M) | 6.06% 7.92% | Perf 5Y | -99.99% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.67 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.04 | EPS Q/Q | 58.71% | Profit Margin | - | RSI (14) | 41.06 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.04 | Sales Q/Q | - | SMA20 | -6.16% ($8.59) | Beta | 1.56 | Target Price | $27 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -15.04% ($9.49) | Rel Volume | 0.3 | Prev Close | $8.09 |
| Employees | 5 | LT Debt/Eq | - | EPS/Sales Surpr. | -56.59% - | SMA200 | -20.73% ($10.17) | Avg Volume(3M) | 0.03M | Price | $8.06 |
| IPO | 2016/7/29 | Option/Short | No/Yes | Trades | 157 | Volume | 10,263 | Change | -0.37% |
뉴스 로딩 중...